Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study ; volume:23 ; number:1 ; day:23 ; month:5 ; year:2023 ; pages:1-11 ; date:12.2023
BMC cardiovascular disorders ; 23, Heft 1 (23.5.2023), 1-11, 12.2023
- Urheber
-
Lin, Ming-Shyan
Wang, Po-Chang
Lin, Meng-Hung
Kuo, Ting-Yu
Lin, Yu-Sheng
Chen, Tien-Hsing
Tsai, Ming-Horng
Yang, Yao-Hsu
Lin, Chun-Liang
Chung, Chang-Min
Chu, Pao-Hsien
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-023-03286-9
- URN
-
urn:nbn:de:101:1-2023091609382833235151
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Ming-Shyan
- Wang, Po-Chang
- Lin, Meng-Hung
- Kuo, Ting-Yu
- Lin, Yu-Sheng
- Chen, Tien-Hsing
- Tsai, Ming-Horng
- Yang, Yao-Hsu
- Lin, Chun-Liang
- Chung, Chang-Min
- Chu, Pao-Hsien
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Effect of severity and etiology of chronic kidney disease in patients with heart failure with mildly reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Effect of severity and etiology of chronic kidney disease in patients with heart failure with mildly reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction